Repair
TB-500
The systemic counterpart to BPC-157, covering the repair pathways that local compounds cannot reach. TB-500 is a synthetic analogue of Thymosin Beta-4, a protein the body produces naturally in response to tissue damage. Its core mechanism is binding G-actin monomers, preventing premature actin polymerisation and allowing controlled cellular migration during structural recovery processes. Unlike locally-acting compounds, TB-500 distributes systemically, meaning it reaches multiple sites simultaneously rather than concentrating at a single point of application. This makes it uniquely relevant to research involving widespread tissue disruption, multi-site recovery modelling, and systemic angiogenesis studies. Studies have demonstrated measurable neovascularisation in cardiac research models, reduced neuronal apoptosis, and promoted remyelination in brain injury models, extending its research relevance well beyond musculoskeletal applications. Most commonly studied alongside BPC-157, with the two compounds covering complementary local and systemic repair pathways within the same protocol.
€79.90 · 10mg
Available options
Product information
The systemic counterpart to BPC-157, covering the repair pathways that local compounds cannot reach. TB-500 is a synthetic analogue of Thymosin Beta-4, a protein the body produces naturally in response to tissue damage. Its core mechanism is binding G-actin monomers, preventing premature actin polymerisation and allowing controlled cellular migration during structural recovery processes. Unlike locally-acting compounds, TB-500 distributes systemically, meaning it reaches multiple sites simultaneously rather than concentrating at a single point of application. This makes it uniquely relevant to research involving widespread tissue disruption, multi-site recovery modelling, and systemic angiogenesis studies. Studies have demonstrated measurable neovascularisation in cardiac research models, reduced neuronal apoptosis, and promoted remyelination in brain injury models, extending its research relevance well beyond musculoskeletal applications. Most commonly studied alongside BPC-157, with the two compounds covering complementary local and systemic repair pathways within the same protocol.